Directory

>

Kathryn Woodburn

avatar

Kathryn Woodburn

Sr Vice President, Preclinical Development | Life Edit Therapeutics

San Francisco, California, United States

View contact details (it's free)

Kathryn Woodburn

Summary

Kathryn Woodburn is an accomplished leader in preclinical development with a robust background in pharmacology and drug development. With extensive experience in gene therapy, oncology, and cardiology, she has successfully guided numerous projects from research through to FDA approval. Kathryn has been instrumental in the development of Hematide, showcasing her expertise in navigating complex regulatory environments. As a regular presenter at scientific conferences and a prolific author, she has contributed significantly to the field through both publications and patents. Currently serving as Sr Vice President at Life Edit, she is also a co-chair of the Biosafe Gene Therapy Committee, reflecting her commitment to advancing gene editing technologies. Her educational background includes a PhD in Chemistry from La Trobe University, further solidifying her technical foundation. Kathryn's unique blend of scientific acumen and leadership experience positions her as a pivotal figure in the pharmaceutical industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Kathryn Woodburn

Work Experience

company logo

Sr Vice President, Preclinical Development at

Life Edit Therapeutics

August 2021 - Present

💼

Independent Consultant at

Pharmacotox Consulting

February 2013 - August 2021

company logo

Executive Director, Preclinical Development at

Adverum Biotechnologies

February 2014 - January 2017

💼

Executive Director, Preclinical Development at

AFFYMAX LIMITED

July 2007 - November 2012

💼

Sr Director, Preclinical Development at

AFFYMAX LIMITED

December 2002 - July 2007

company logo

Director of Preclinical Research at

AP Pharma

October 2001 - November 2002

company logo

Director of Preclinical Research at

Pharmacyclics, an AbbVie Company

September 1994 - September 2001

Logos provided by Logo.dev

Kathryn Woodburn

Education

Wayne State University School of Medicine, Post Doctoral Fellow

January 1992 - January 1994

University of Toledo, Post Doctoral Research Fellow

January 1992 - January 1992

La Trobe University, Phd

January 1988 - January 1992

La Trobe University, Bsc (Hons)

January 1987 - January 1987

Frequently Asked Questions about Kathryn Woodburn

What is Kathryn Woodburn email address?

Kathryn Woodburn's primary email address is *********@lifeeditinc.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kathryn Woodburn work for?

Kathryn Woodburn is a Sr Vice President, Preclinical Development at Life Edit Therapeutics, a company specializing in Commercial physical research.

Where Kathryn Woodburn graduated from?

Kathryn Woodburn holds a degree in Pharmacology from Wayne State University School of Medicine.

How can I directly contact Kathryn Woodburn?

To contact Kathryn Woodburn directly, you can use the email address *********@lifeeditinc.com. Complete contact information is available upon registration with Muraena.

Who is Kathryn Woodburn?

Kathryn Woodburn is an accomplished leader in preclinical development with a robust background in pharmacology and drug development. With extensive experience in gene therapy, oncology, and cardiology, she has successfully guided numerous projects from research through to FDA approval. Kathryn has been instrumental in the development of Hematide, showcasing her expertise in navigating complex regulatory environments. As a regular presenter at scientific conferences and a prolific author, she has contributed significantly to the field through both publications and patents. Currently serving as Sr Vice President at Life Edit, she is also a co-chair of the Biosafe Gene Therapy Committee, reflecting her commitment to advancing gene editing technologies. Her educational background includes a PhD in Chemistry from La Trobe University, further solidifying her technical foundation. Kathryn's unique blend of scientific acumen and leadership experience positions her as a pivotal figure in the pharmaceutical industry.

Kathryn`s contact details

mail

*********@lifeeditinc.com

Colleagues

avatar
Gunjan Arya Pmp

Vice President of Membership

avatar
Shaorong Chong

Vice President Of CRISPR Technology Development

avatar
Kareem Reda

Chief Operating Officer

avatar
Hélène Svahnqvist

Head of Alliance Management, Vice President

avatar
Joel Parker

Vice President, Computational Biology & Bioinformatics

View Contact details (it's free)
Request Profile Removal